Investor mix
10 investors on record; lead investors include Ysios Capital, Kurma Partners, Next47, Gilde Healthcare; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 60% |
| Private equity | 2 | 20% |
| Other / undisclosed | 2 | 20% |
Provider of a diagnostic platform for molecular diagnostics and immunoassays
10 investors on record; lead investors include Ysios Capital, Kurma Partners, Next47, Gilde Healthcare; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 60% |
| Private equity | 2 | 20% |
| Other / undisclosed | 2 | 20% |